用户名: 密   码:
注册 | 忘记密码?
专利信息
查询条件 展开筛选条件
  • [药品] 包含 'Oxybutynin'
排序 翻到页码
标题标题2专利权人发明人附图摘要摘要2优先权号IPC专利类型
首页123456下页尾页334 条记录, 当前第1/34页。
公开号 公开日 申请号 申请日
1. AU2008259864C1 2014/3/6
专利标题:Methods and compositions for administration of oxybutynin 法律状态
Administration of Oxybutynin in nebulized dry powder form directly to a patient's lungs for treating urinary incontinence or respiratory disease.


2. US8658683B2 2014/2/25 US13/593173 2012/8/23
专利标题:Combination of alpha-2 receptor agonist (clonidin) and anti-muscarinic agent (oxybutynin) for the treatment of sialorrhoea 法律状态
An alpha2 adrenoreceptor agonist eg. clonidine brimonidine monoxidine lofexidine is useful for the treatment of siaiorrhoea administered by the paraungual sublingual or buccal route. The patient to be treated is also given an anti-muscarinic agent eg. oxybutynin glycopyrrolate ipratropium.


3. EP2427172A4 2014/2/19
专利标题:A method for treating overactive bladders and a device for storage and administration of topical oxybutynin compositions 法律状态
专利权人Watson Laboratories, Inc.;


4. US20140046275A1 2014/2/13
专利标题:Method for treating overactive bladders and a device for storage and administration of topical oxybutynin compositions 法律状态
专利权人Watson Laboratories, Inc.;
The invention relates to a method for treating overactive bladders and a device for storing and administering non-occluded oxybutynin topical compositions.


5. US2014046275A1 2014/2/13 US201314059671 2013/10/22
专利标题:Method for Treating Overactive Bladders and a Device for Storage and Administration of Topical Oxybutynin Compositions 法律状态
专利权人WATSON LAB INC [US];
The invention relates to a method for treating overactive bladders and a device for storing and administering non-occluded oxybutynin topical compositions.


6. US2014037713A1 2014/2/6 US201313791840 2013/3/8
专利标题:TRANSDERMAL COMPOSITIONS FOR ANTI-CHOLINERGIC AGENTS 法律状态
The present invention relates generally to compositions or formulations for transdermal or transmucosal administration of anti-cholinergic agents such as oxybutynin. The invention utilizes a novel delivery vehicle and is a substantially malodorous-free and irritation free transdermal formulation which is substantially live of long chain fatty alcohols, long-chain fatty acids, and long-chain fatty esters. A method is disclosed for treating a subject for hyperhidrosis with these formulations while...


7. PT1986642E 2014/1/30 PT20070705370T 2007/2/12
专利标题:COMBINATION OF ALPHA-2 RECEPTOR AGONIST (CLONIDINE) AND AN ANTI-MUSCARINIC AGENT (OXYBUTYNIN) FOR THE TREATMENT OF SIALORRHOEA 法律状态


8. TW201347794A 2013/12/1 TW20130120804 2013/6/11
专利标题:Medicine adhesive patch and manufacturing method thereof 法律状态
The present invention relates to a medicine adhesive patch and its manufacturing method thereof. The method consisting of manufacturing a support layer and a medicine adhesive patch layer disposed on at least one side of the support layer, and comprising the following steps: (A) obtaining the medicine adhesive patch layer compositions: oxybutynin hydrochloride used as medicine, at least one selected from the group composed of acrylic adhesive based polymer and a rubber polymer used as the adhesi...


9. CN103385854A 2013/11/13 CN20121141064 2012/5/9
专利标题:Oxybutynin chloride externally-applied preparation and preparation method thereof 法律状态


10. EP1986642B1 2013/11/13 EP20070705370 2007/2/12
专利标题:Combination of alpha-2 receptor agonist (clonidine) and an anti-muscarinic agent (oxybutynin) for the treatment of sialorrhoea 法律状态



首页123456下页尾页334 条记录, 当前第1/34页。

下载范围

下载第 条记录。

下载内容

题录信息 专利全文